Isomorphic Labs’ funding highlights AI’s potential to revolutionize drug discovery, but success hinges on bridging computational and clinical gaps.

The post Isomorphic Labs raises $2.1B for AI-powered drug discovery, backed by Alphabet and sovereign wealth funds appeared first on Crypto Briefing.